158 related articles for article (PubMed ID: 22673565)
1. Duodenal adenocarcinoma with neuroendocrine features in a patient with acromegaly and thyroid papillary adenocarcinoma: a unique combination of endocrine neoplasia.
Kato K; Takeshita Y; Misu H; Ishikura K; Kakinoki K; Sawada-Kitamura S; Kaneko S; Takamura T
Endocr J; 2012; 59(9):791-6. PubMed ID: 22673565
[TBL] [Abstract][Full Text] [Related]
2. [Primary thyroid and breast cancers in a patient with pituitary adenoma and acromegaly].
Marova EI; Bazarova EN; Bronshteĭn MI; Rozhinskaia LIa; Karetnikov IuP
Sov Med; 1983; (7):119-22. PubMed ID: 6137876
[No Abstract] [Full Text] [Related]
3. Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinoma.
Sisson JC; Giordano TJ; Avram AM
Thyroid; 2012 Apr; 22(4):430-6. PubMed ID: 22385288
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of thyrotropin-producing pituitary adenoma with papillary adenocarcinoma of the thyroid--a case report and surgical strategy.
Ohta S; Nishizawa S; Oki Y; Namba H
Pituitary; 2001 Sep; 4(4):271-4. PubMed ID: 12501979
[TBL] [Abstract][Full Text] [Related]
5. Poorly-controlled acromegaly accompanied by subclinical adrenal Cushing's syndrome after surgery for multiple endocrine tumors.
Ishikawa M; Kato M; Sasaki H; Morii T; Fujita H; Kakei M; Narita T; Yamada Y
Intern Med; 2015; 54(6):617-20. PubMed ID: 25786452
[TBL] [Abstract][Full Text] [Related]
6. [Effective treatment with constant subcutaneous infusion of octreotide in a patient with acromegaly associated with diabetic pre-coma and diabetes insipidus].
Abe T; Ohguni S; Tanigawa K; Kato Y
Nihon Naibunpi Gakkai Zasshi; 1994 Nov; 70(9):1029-38. PubMed ID: 7851621
[TBL] [Abstract][Full Text] [Related]
7. Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection.
Mozas J; Ocón E; López de la Torre M; Suárez AM; Miranda JA; Herruzo AJ
Int J Gynaecol Obstet; 1999 Apr; 65(1):71-3. PubMed ID: 10390105
[TBL] [Abstract][Full Text] [Related]
8. Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1.
Hozumi K; Fukuoka H; Odake Y; Takeuchi T; Uehara T; Sato T; Inoshita N; Yoshida K; Matsumoto R; Bando H; Hirota Y; Iguchi G; Taniguchi M; Otsuki N; Nishigori C; Kosaki K; Hasegawa T; Ogawa W; Takahashi Y
Endocr J; 2019 Oct; 66(10):853-857. PubMed ID: 31189769
[TBL] [Abstract][Full Text] [Related]
9. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
[TBL] [Abstract][Full Text] [Related]
10. Impact of preoperative pasireotide therapy on invasive octreotide-resistant acromegaly.
Yamamoto R; Robert Shima K; Igawa H; Kaikoi Y; Sasagawa Y; Hayashi Y; Inoshita N; Fukuoka H; Takahashi Y; Takamura T
Endocr J; 2018 Oct; 65(10):1061-1067. PubMed ID: 30078825
[TBL] [Abstract][Full Text] [Related]
11. Differentiated thyroid carcinoma in sporadic and familial presentations of acromegaly: A case series.
Rogozinski A; Daly AF; Reyes A; Furioso A; Beckers A; Lowenstein A
Ann Endocrinol (Paris); 2020 Oct; 81(5):482-486. PubMed ID: 32822652
[TBL] [Abstract][Full Text] [Related]
12. Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.
Duan L; Zhu H; Xing B; Gu F
BMC Endocr Disord; 2017 Sep; 17(1):55. PubMed ID: 28874187
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of pituitary adenomas.
Laws ER
Curr Probl Cancer; 1984 Feb; 8(8):1-26. PubMed ID: 6145544
[TBL] [Abstract][Full Text] [Related]
14. Desensitization to somatostatin analogue (Octreotide) observed in a patient with acromegaly.
Haraguchi K; Ohtaka M; Takazawa K; Endo T; Onaya T
Endocr J; 1995 Apr; 42(2):295-300. PubMed ID: 7627275
[TBL] [Abstract][Full Text] [Related]
15. Octreotide improved ventricular arrhythmia in an acromegalic patient.
Suyama K; Uchida D; Tanaka T; Saito J; Noguchi Y; Nakamura S; Tatsuno I; Saito Y; Saeki N
Endocr J; 2000 Mar; 47 Suppl():S73-5. PubMed ID: 10890189
[TBL] [Abstract][Full Text] [Related]
16. [Hypercalcemia, hypercorticism, hypergastrinemia and hypothyroidism following adenoma of the anterior pituitary lobe].
Salomon F; Läng H
Schweiz Rundsch Med Prax; 1994 Jan; 83(4):106-10. PubMed ID: 7906899
[No Abstract] [Full Text] [Related]
17. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Plöckinger U; Quabbe HJ
Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
[TBL] [Abstract][Full Text] [Related]
18. A rare case of gastric cancer in an acromegalic patient.
Asai K; Shimoyama S; Sanno N; Kaminishi M; Oohara T
J Gastroenterol; 1997 Aug; 32(4):528-32. PubMed ID: 9250902
[TBL] [Abstract][Full Text] [Related]
19. Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
Karavitaki N; Turner HE; Adams CB; Cudlip S; Byrne JV; Fazal-Sanderson V; Rowlers S; Trainer PJ; Wass JA
Clin Endocrinol (Oxf); 2008 Jun; 68(6):970-5. PubMed ID: 18031313
[TBL] [Abstract][Full Text] [Related]
20. Hyperthyroidism in a patient with TSH-producing pituitary adenoma coexisting with thyroid papillary adenocarcinoma.
Kishida M; Otsuka F; Kataoka H; Yokota K; Oishi T; Yamauchi T; Doihara H; Tamiya T; Mimura Y; Ogura T; Makino H
Endocr J; 2000 Dec; 47(6):731-8. PubMed ID: 11228048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
